George Emmanuel

714 total citations
11 papers, 526 citations indexed

About

George Emmanuel is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, George Emmanuel has authored 11 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in George Emmanuel's work include Systemic Sclerosis and Related Diseases (3 papers), Sepsis Diagnosis and Treatment (2 papers) and Neonatal Respiratory Health Research (2 papers). George Emmanuel is often cited by papers focused on Systemic Sclerosis and Related Diseases (3 papers), Sepsis Diagnosis and Treatment (2 papers) and Neonatal Respiratory Health Research (2 papers). George Emmanuel collaborates with scholars based in United States. George Emmanuel's co-authors include Duane C. Bloedow, John P. Pribble, Charles J. Fisher, David P. Ng, Michael A. Catalano, Steven M. Opal, Roger C. Bone, Gus J. Slotman, David S. Kaplan and Herman Ellman and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and CHEST Journal.

In The Last Decade

George Emmanuel

11 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Emmanuel United States 9 231 173 147 98 93 11 526
K.-H. Staubach Germany 10 235 1.0× 151 0.9× 114 0.8× 16 0.2× 70 0.8× 17 560
Slotman Gj United States 5 138 0.6× 138 0.8× 55 0.4× 15 0.2× 71 0.8× 9 344
G. Pilz Germany 11 344 1.5× 99 0.6× 86 0.6× 20 0.2× 52 0.6× 28 654
Bernadette Garvey Canada 13 54 0.2× 109 0.6× 99 0.7× 57 0.6× 63 0.7× 22 714
Kimberly Nieman United States 10 84 0.4× 147 0.8× 60 0.4× 66 0.7× 40 0.4× 15 487
Charles E. Rath United States 18 89 0.4× 53 0.3× 72 0.5× 49 0.5× 55 0.6× 32 754
Fritz Reinhard Matthias Germany 11 251 1.1× 38 0.2× 277 1.9× 13 0.1× 61 0.7× 39 669
Hanna Dückers Germany 9 227 1.0× 76 0.4× 100 0.7× 18 0.2× 78 0.8× 10 579
Shapiro Mj United States 5 156 0.7× 135 0.8× 47 0.3× 9 0.1× 84 0.9× 7 368
John Milton Mishler United States 14 70 0.3× 53 0.3× 68 0.5× 26 0.3× 27 0.3× 44 674

Countries citing papers authored by George Emmanuel

Since Specialization
Citations

This map shows the geographic impact of George Emmanuel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Emmanuel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Emmanuel more than expected).

Fields of papers citing papers by George Emmanuel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Emmanuel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Emmanuel. The network helps show where George Emmanuel may publish in the future.

Co-authorship network of co-authors of George Emmanuel

This figure shows the co-authorship network connecting the top 25 collaborators of George Emmanuel. A scholar is included among the top collaborators of George Emmanuel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Emmanuel. George Emmanuel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Fisher, Charles J., Gus J. Slotman, Steven M. Opal, et al.. (1994). Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trial. Critical Care Medicine. 22(1). 12–21. 351 indexed citations
2.
DiBianco, Robert, John O. Parker, Simon Chakko, et al.. (1991). Doxazosin for the treatment of chronic congestive heart failure: Results of a randomized double-blind and placebo-controlled study. American Heart Journal. 121(1). 372–380. 13 indexed citations
3.
Chmel, Herman, et al.. (1990). A prospective, double-blind, randomized study comparing the efficacy and safety of low-dose ciprofloxacin with ampicillin in the treatment of bronchitis. Diagnostic Microbiology and Infectious Disease. 13(2). 149–151. 10 indexed citations
4.
Munger, Mark A., William F. Rutherford, Francisco M. González, et al.. (1990). Assessment of intravenous fenoldopam mesylate in the management of severe systemic hypertension. Critical Care Medicine. 18(5). 502–504. 19 indexed citations
5.
Gorelick, Kenneth J., Roland M.H. Schein, Neil R. MacIntyre, George Emmanuel, & Gordon R. Bernard. (1990). MULTICENTER TRIAL OF ANTIENDOTOXIN ANTIBODY E5 IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS (GNS). Critical Care Medicine. 18(Supplement). S253–S253. 8 indexed citations
6.
Guttadauria, Maria, Herman Ellman, George Emmanuel, David S. Kaplan, & Herbert S. Diamond. (1977). Pulmonary Function in Scleroderma. Arthritis & Rheumatism. 20(5). 1071–1079. 75 indexed citations
7.
Emmanuel, George, et al.. (1976). Environmental Factors and the Diffusing Capacity of the Lung in Progressive Systemic Sclerosis. CHEST Journal. 69(2). 304–307. 24 indexed citations
8.
Kaplan, David S., et al.. (1972). PHENFORMIN AND ETHYLŒSTRENOL IN SCLERODERMA. The Lancet. 299(7758). 1023–1023. 3 indexed citations
9.
Emmanuel, George, et al.. (1971). A New Mechanism of Acute Pulmonary Edema. CHEST Journal. 59(5). 26S–27S. 1 indexed citations
10.
Kottmeier, Peter K., et al.. (1969). Growth and function of the replanted lung in young dogs. Journal of Pediatric Surgery. 4(1). 66–76. 11 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026